BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9122203)

  • 1. Aberrant trafficking of hepatitis B virus glycoproteins in cells in which N-glycan processing is inhibited.
    Lu X; Mehta A; Dadmarz M; Dwek R; Blumberg BS; Block TM
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2380-5. PubMed ID: 9122203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that N-linked glycosylation is necessary for hepatitis B virus secretion.
    Lu X; Mehta A; Dwek R; Butters T; Block T
    Virology; 1995 Nov; 213(2):660-5. PubMed ID: 7491790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the downstream signal sequences in the maturation of the HBV middle surface glycoprotein: development of a novel therapeutic vaccine candidate.
    Liu Y; Simsek E; Norton P; Sinnathamby G; Philip R; Block T; Zhou T; Mehta A
    Virology; 2007 Aug; 365(1):10-9. PubMed ID: 17462693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus MHBs antigen is selectively sensitive to glucosidase-mediated processing in the endoplasmic reticulum.
    Lu X; Lu Y; Geschwindt R; Dwek RA; Block TM
    DNA Cell Biol; 2001 Oct; 20(10):647-56. PubMed ID: 11749723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity.
    Lazar C; Durantel D; Macovei A; Zitzmann N; Zoulim F; Dwek RA; Branza-Nichita N
    Antiviral Res; 2007 Oct; 76(1):30-7. PubMed ID: 17548120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttranslational N-glycosylation of the hepatitis B virus large envelope protein.
    Lambert C; Prange R
    Virol J; 2007 May; 4():45. PubMed ID: 17537250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus (HBV) envelope glycoproteins vary drastically in their sensitivity to glycan processing: evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion.
    Mehta A; Lu X; Block TM; Blumberg BS; Dwek RA
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1822-7. PubMed ID: 9050863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of host ER glucosidase activity prevents Golgi processing of virion-associated bovine viral diarrhea virus E2 glycoproteins and reduces infectivity of secreted virions.
    Jordan R; Nikolaeva OV; Wang L; Conyers B; Mehta A; Dwek RA; Block TM
    Virology; 2002 Mar; 295(1):10-9. PubMed ID: 12033761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel function of the endoplasmic reticulum degradation-enhancing α-mannosidase-like proteins in the human hepatitis B virus life cycle, mediated by the middle envelope protein.
    Lazar C; Uta M; Petrescu SM; Branza-Nichita N
    Cell Microbiol; 2017 Feb; 19(2):. PubMed ID: 27490136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced secretion of virions and hepatitis B virus (HBV) surface antigen of a naturally occurring HBV variant correlates with the accumulation of the small S envelope protein in the endoplasmic reticulum and Golgi apparatus.
    Chua PK; Wang RY; Lin MH; Masuda T; Suk FM; Shih C
    J Virol; 2005 Nov; 79(21):13483-96. PubMed ID: 16227269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biogenesis of the hepatitis B viral middle (M) surface protein in a human hepatoma cell line: demonstration of an alternative secretion pathway.
    Sheu SY; Lo SJ
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():3031-9. PubMed ID: 7964612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus large and middle glycoproteins are degraded by a proteasome pathway in glucosidase-inhibited cells but not in cells with functional glucosidase enzyme.
    Simsek E; Mehta A; Zhou T; Dwek RA; Block T
    J Virol; 2005 Oct; 79(20):12914-20. PubMed ID: 16188993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of N-oligosaccharide endoplasmic reticulum processing reactions in glycoprotein folding and degradation.
    Parodi AJ
    Biochem J; 2000 May; 348 Pt 1(Pt 1):1-13. PubMed ID: 10794707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin.
    Block TM; Lu X; Platt FM; Foster GR; Gerlich WH; Blumberg BS; Dwek RA
    Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2235-9. PubMed ID: 8134380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor.
    Li J; Zong L; Sureau C; Barker L; Wands JR; Tong S
    J Virol; 2016 Sep; 90(18):8302-13. PubMed ID: 27384660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular synthesis, processing, and transport of proteins encoded by ORFs 5 to 7 of porcine reproductive and respiratory syndrome virus.
    Mardassi H; Massie B; Dea S
    Virology; 1996 Jul; 221(1):98-112. PubMed ID: 8661418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of aglycone structures on N-glycan processing reactions in the endoplasmic reticulum.
    Totani K; Yamaya K; Hirano M; Ito Y
    Carbohydr Res; 2017 Feb; 439():16-22. PubMed ID: 28064042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chaperones involved in hepatitis B virus morphogenesis.
    Prange R; Werr M; Löffler-Mary H
    Biol Chem; 1999 Mar; 380(3):305-14. PubMed ID: 10223333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus subviral envelope particle morphogenesis and intracellular trafficking.
    Patient R; Hourioux C; Sizaret PY; Trassard S; Sureau C; Roingeard P
    J Virol; 2007 Apr; 81(8):3842-51. PubMed ID: 17267490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Glycosylation and N-Glycan Processing in HBV Biology and Pathogenesis.
    Dobrica MO; Lazar C; Branza-Nichita N
    Cells; 2020 Jun; 9(6):. PubMed ID: 32512942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.